Literature DB >> 1608677

Management of penicillin-resistant pneumococcal infections.

I R Friedland1, G R Istre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1608677     DOI： 10.1097/00006454-199206000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  22 in total

1.  Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.

Authors:  T A Davies; L M Kelly; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Antipneumococcal activity of ertapenem (MK-0826) compared to those of other agents.

Authors:  Glenn A Pankuch; Todd A Davies; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

3.  Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001.

Authors:  Mar Ortega; Francesc Marco; Alex Soriano; Elisa García; José A Martínez; Josep Mensa
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Antipneumococcal activities of gemifloxacin compared to those of nine other agents.

Authors:  T A Davies; L M Kelly; G A Pankuch; K L Credito; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

5.  Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.

Authors:  Klaudia Kosowska-Shick; Kim Credito; Glenn A Pankuch; Gengrong Lin; Bülent Bozdogan; Pamela McGhee; Bonifacio Dewasse; Dong-Rack Choi; Jei Man Ryu; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

6.  Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  In vitro activities of oxazolidinones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  E O Mason; L B Lamberth; S L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors:  C L Clark; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  Antipneumococcal activity of ABT-773 compared to those of 10 other agents.

Authors:  T A Davies; L M Ednie; D M Hoellman; G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

10.  Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae.

Authors:  D L Kiska; A Kerr; M C Jones; N N Chazotte; B Eskridge; S Miller; M Jordan; C Sheaffer; P H Gilligan
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.